Quality Risk Assessment for Solid Oral Dosage Forms for New Product Introduction
OBJECTIVE
Evaluate and control quality risks before introducing a new oral liquid product to ensure patient safety, product quality, process robustness, and GMP compliance.
KEY RISK AREAS
1️⃣ Product & Formulation
- API–excipient compatibility
- Solubility / suspension characteristics
- CQAs: assay, pH, viscosity, microbial limits
- Preservative effectiveness
- Taste, appearance & physical stability
- Chemical & physical stability
2️⃣ Manufacturing Process
- Dispensing → compounding → mixing → filtration/homogenization → filling
- Order and rate of ingredient addition
- Mixing time & speed
- Temperature control
- Homogeneity / uniformity
- Hold-time risks
3️⃣ Microbiological Risks
- Microbial contamination
- Microbial growth during manufacturing
- Bioburden control
- Preservative system effectiveness
- Water-system quality
- Environmental & personnel hygiene
4️⃣ Facility & Utilities
- Manufacturing-area suitability
- HVAC & environmental conditions
- Purified Water system
- Compressed air, where applicable
- Material & personnel flow
- Temperature / humidity control
5️⃣ Equipment
- Mixer / homogenizer suitability
- Product-contact material compatibility
- Equipment capacity
- Equipment qualification & calibration
- Dead-leg / stagnant-area risks
- Cleaning and changeover requirements
6️⃣ Cleaning & Validation
- Cleaning validation
- Cross-contamination control
- Maximum allowable carryover
- Dirty/clean hold times
- Process validation
- Analytical method suitability
7️⃣ Filling & Packaging
- Filling-volume accuracy
- Container-closure compatibility
- Leakage / seal integrity
- Light & moisture protection
- Container interaction / extractables & leachables, where applicable
- Label mix-up and line-clearance risks
8️⃣ Stability & Documentation
- Accelerated & long-term stability
- In-use stability, where applicable
- pH / viscosity / assay trends
- Microbial-limit trends
- SOPs & batch records
- Change Control, Deviation & CAPA
- QRM/FMEA documentation
RISK ASSESSMENT FLOW
New Product
↓
Identify Hazards
↓
Assess Risk
(Severity × Occurrence × Detectability)
↓
FMEA / Risk Matrix
↓
Define Risk Controls
↓
Qualification & Validation
↓
QA Approval
↓
Continued Monitoring
QA FOCUS
“Before introducing a new non-sterile oral liquid product, evaluate formulation, microbiological, water-system, process, equipment, cleaning, filling, packaging, and stability risks—and ensure identified risks are adequately controlled through QRM, qualification, and validation.”
Remember Keywords:
CQA • CPP • QRM • FMEA • Microbial Control • Preservative Effectiveness • Purified Water • Process Validation • Cleaning Validation • Stability • Cross-Contamination • GMP